What Creative Proteomics does

Creative Proteomics is a privately held contract research organization (CRO) headquartered in Shirley, USA, with a European contact office in Germany and approximately 51–100 employees. The company delivers mass spectrometry-based analytical services across proteomics, metabolomics, lipidomics, glycomics, peptidomics, and bioinformatics, using platforms including LC-MS/MS, GC-MS, ion mobility spectrometry, NMR spectroscopy, and SPR/Biacore. It serves pharmaceutical and biotechnology organizations, academic research institutions, and plant science researchers, providing fee-for-service laboratory analysis via a custom quote-based pricing model and direct online inquiry/ordering.

The company's core product portfolio is organized around six service pillars (Proteomics, Metabolomics, Lipidomics, Glycomics, Bioinformatics) augmented by specialized offerings including spatial omics, multi-omics integration, single-cell metabolomics and transcriptomics, flow cytometry, amino acid analysis, host cell protein analysis, and custom peptide/protein synthesis. MassTarget™ functions as a drug-discovery-focused sub-brand bundling MS-based binding assays (AS-MS, BLI, native ESI-MS), chemoproteomics (ABPP-MS), thermal proteomics (TPP, TSA), high-throughput MS screening, ADME/DMPK/PK-PD, and AI-driven multi-omics integration for pharmaceutical R&D customers. AI/ML capabilities are integrated into bioinformatics pipelines through third-party tools such as SIRIUS/CSI:FingerID, GNPS molecular networking, and deep learning peak detection models.

The business operates a sales-led, B2B laboratory services go-to-market model with digital-first customer acquisition through an SEO-optimized website, content marketing, social media, and 24/7 customer service. Customers submit project descriptions and receive customized project plans and quotes. The company distributes globally through direct website ordering, email/phone inquiries, and a distributor network. Notable disclosed customers include AbbVie, University of Cambridge, Oxford, Yale, Stanford, Berkeley, Toronto, Georgia Tech, Louisville, and Brigham and Women's Hospital. No funding, M&A, or revenue disclosures are available, and the company has no parent organization or public listing.

Name

Creative Proteomics

Legal name

Creative Proteomics

Website

https://creative-proteomics.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Creative Proteomics is a US-based CRO providing mass spectrometry-based proteomics, metabolomics, lipidomics, glycomics, and bioinformatics services to pharmaceutical companies, academic institutions, and plant science researchers via a custom quote-based, fee-for-service model.

Ownership category

akta.pro rank

Product category

Analytical Laboratory Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

akta.pro primary industry

Proteomics & Mass Spectrometry Services (HLAGANAB)

akta.pro secondary industries

Proteomics & Biomarker Analytical Testing (HLAGADAG), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation) (HLAAAIAI)

Keywords

• Proteomics services
• Metabolomics analysis
• Mass spectrometry
• Lipidomics profiling
• Bioinformatics analysis

Headquarters

HQ city

Shirley

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Testing Services: Fee-for-service laboratory analysis for proteomics, metabolomics, glycomics, lipidomics, and bioinformatics. Customers submit samples and receive analytical results with data interpretation. Pricing is quote-based based on sample complexity and analysis requirements.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Creative Proteomics is a contract research organization that delivers mass spectrometry- and NMR-based analytical services spanning proteomics, metabolomics, lipidomics, glycomics, peptidomics, spatial omics, and bioinformatics. Customers submit biological samples and receive quantitative analytical results with data interpretation, supported by specialized drug discovery offerings via its MassTarget™ platform. The company serves pharmaceutical, biotechnology, and academic research customers globally.

Product overview

Creative Proteomics operates as a multi-service omics provider offering a portfolio of interrelated analytical services centered on mass spectrometry and NMR-based platforms. The core offering consists of six main service pillars: Proteomics Service, Metabolomics Service, Lipidomics Service, Glycomics Service, and Bioinformatics Service, each available as standalone offerings. These core services are augmented by specialized sub-services (Peptidomics, Spatial Omics, Multi-omics Integrative Services) and adjacent offerings (Flow Cytometry, Amino Acid Analysis, Host Cell Protein Analysis). The MassTarget™ sub-brand functions as a drug-discovery-specific platform within the broader portfolio, bundling MS-based binding assays, chemoproteomics, thermal proteomics, high-throughput screening, ADME/DMPK, and AI-driven multi-omics integration specifically for pharmaceutical R&D. Technology foundations span LC-MS/MS, GC-MS, NMR spectroscopy, ion mobility MS, and SPR/Biacore, applied across human/animal, plant, and microbial sample types.

Differentiator

Problem solved

Functional benefit

Products and services

• Proteomics Service Comprehensive proteomics service encompassing protein identification, quantification, post-translational modification analysis, protein-protein interaction studies, top-down and peptidomics approaches, de novo sequencing, and subcellular proteomics using LC-MS/MS platforms. Targeted at pharmaceutical, biotech, and academic researchers.
• Metabolomics Service Full-spectrum metabolomics services spanning untargeted and targeted metabolomics, metabolic flux analysis, unknown metabolite identification, xenobiotic metabolite analysis, and plant metabolomics using LC-MS/MS and GC-MS platforms. For pharma, biotech, academic, plant science, and microbiome researchers.
• Lipidomics Service Qualitative and quantitative analysis of lipids and their metabolic pathways, including untargeted and targeted lipidomics for plants, yeast, and mammals, covering fatty acids, sphingolipids, glycerolipids, phospholipids, ceramides, sterols, and eicosanoids.
• Glycomics Service Glycomics services including N-glycan and O-glycan profiling, glycan quantification and sequencing, structural characterization of glycans, glycopeptide analysis, glycan-related microarray assays, polysaccharide analysis, and starch analysis.
• Bioinformatics Service Bioinformatics support for proteomics and metabolomics studies including functional annotation, enrichment analysis, clustering analysis, statistical analysis, network analysis, and multivariate analysis to interpret high-throughput omics data.
• Spatial Omics Services Spatial omics services encompassing digital and molecular pathology, spatial metabolomics via MALDI-MSI, DESI-MSI, and LA-ICP-MS imaging, spatial transcriptomics, spatial proteomics, and integrated spatial multi-omics profiling.
• Multi-omics Integrative Services Integrated multi-omics analysis combining transcriptomics, proteomics, metabolomics, lipidomics, metagenomics, and epigenomics data to provide comprehensive biological insights for drug discovery and disease research.
• Peptidomics Service Peptidomics service for identification and quantitative analysis of endogenous peptides in biological samples, including characterization of peptide biomarkers, untargeted peptidomics, and immunopeptidomics using LC-MS/MS.
• Customized Synthesized Peptide and Proteins Custom peptide and protein synthesis services using various synthetic methods with quality assurance documentation for pharmaceutical and biotechnology research applications.
• MassTarget™ Drug Discovery Platform Drug discovery platform offering label-free binding and affinity services (AS-MS, BLI, CE-MS, native ESI-MS, ion mobility MS), protein footprinting (FPOP, HDX-MS, LiP-MS), thermal shift proteomics (TPP, TSA, PISA), chemoproteomics (ABPP-MS), high-throughput MS screening, enzyme activity assays, cell-based MS drug screening, ADME/DMPK/PK-PD research, and multi-omics integration.
• Flow Cytometry Service Flow cytometry and FACS sorting services for single-cell analysis applications in research and diagnostics.
• Amino Acid Analysis (AAA) Analytical service for amino acid quantification and characterization in biological samples.
• Host Cell Protein Analysis Identification and quantification of residual host cell proteins in biopharmaceutical manufacturing processes for quality control.
• De Novo Peptide and Protein Sequencing Peptide and protein de novo sequencing service for identifying novel peptides, unsequenced organisms, and antibody drugs that cannot be detected by database search methods.
• SPR Assay Service (Biacore) Surface Plasmon Resonance (SPR) assay service using Biacore instruments for label-free, real-time measurement of biomolecular interactions including binding kinetics and affinity determination.
• Single Cell Metabolomics Single-cell metabolomics services profiling the metabolome of individual cells using nanoESI-MS and ion mobility spectrometry to reveal metabolic heterogeneity at cellular resolution.
• Single Cell Transcriptomics

Quantifiable outcome

• Detection of 200+ metabolites per single cell using advanced IMS-resolved nanoESI-MS techniques
• +1 more outcomes

Named customers13 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Metabolon: Specialized metabolomics CRO offering untargeted and targeted metabolite profiling services using mass spectrometry. Directly comparable to Creative Proteomics's metabolomics service line and competes for the same pharma and academic sponsors.
• Biognosys: Proteomics-focused CRO providing discovery proteomics, targeted proteomics (using its Spectronaut software), and protein biomarker services. Most direct head-to-head competitor for Creative Proteomics's proteomics service line.
• Novogene: Multi-omics services provider offering genomics, proteomics, and metabolomics on a fee-for-service basis. Directly comparable service model, customer mix, and global intake footprint.

Broad incumbents

• Eurofins Scientific: Global testing CRO with a sizeable biopharma services division covering proteomics, metabolomics, and genomics. Overlaps broadly with Creative Proteomics but operates at vastly larger scale and with broader geographic reach.
• Charles River Laboratories: Large CRO offering discovery, safety assessment, and laboratory services including protein characterization and bioanalytical support. A scaled incumbent competing for the same biopharma outsourcing dollars.
• Thermo Fisher Scientific (PPD): Owns both the dominant mass-spectrometry instrument line (Orbitrap, Q Exactive) used by Creative Proteomics and the PPD CRO business. A vertically integrated incumbent that competes as both vendor and analytical-services provider.
• WuXi AppTec: Global CRO/CDMO offering discovery, preclinical, and laboratory services to biopharma. Competes on multi-omics and bioanalytical work and operates at much larger scale with broader geographic coverage.
• Evotec: Drug-discovery CRO offering proteomics, metabolomics, and integrated multi-omics as part of broader discovery collaborations. Overlaps with Creative Proteomics's MassTarget drug-discovery workflow.
• GenScript: Life-science services company offering gene synthesis, protein production, peptide synthesis, and analytical services. Comparable on the custom peptide/protein synthesis and protein characterization lines, broader in scope elsewhere.

Emerging players

• Olink Holding: Proteomics platform company offering targeted protein biomarker analysis via Proximity Extension Assay. Adjacent rather than direct, since Olink sells a kit-and-platform model, but it overlaps with Creative Proteomics's targeted proteomics workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/CDProteomics
• Facebookfacebook.com/842406995793038
• LinkedInlinkedin.com/company/creative-proteomics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Creative Proteomics